| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, NF-
B, and AP-1 Activation
1 Division of Cardiology, University of Texas HSC, San Antonio, Texas, United States
2 Medicine, University of Texas HSC, San Antonio, Texas, United States
3 Periodontitis, Univ. of Texas HSC at San Antonio, San Antonio, Texas, United States
4 Medicine, Dartmouth Medical School, New Hampshire, Connecticut, United States
5 Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
* To whom correspondence should be addressed. E-mail: chandraseka{at}uthscsa.edu.
Matrix metalloproteinases (MMPs) degrade collagen, and mediate tissue remodeling. The novel cytokine interleukin (IL)-17 is expressed during various inflammatory conditions and modulates MMP expression. We investigated the effect of IL-17 on MMP1 expression in primary human cardiac fibroblasts (HCF), and delineated the signaling pathways involved. HCF were treated with recombinant human (rh) IL-17. MMP1 expression was analyzed by Northern blotting, RT-qPCR, Western blotting and ELISA; transcriptional induction and transcription factor (TF) binding by EMSA, ELISA and reporter assay; p38 MAPK and ERK1/2 activation by protein kinase assays and Western blotting. Signal transduction pathways were investigated using pharmacological inhibitors, siRNA, and adenoviral dominant negative (dn) expression vectors. IL-17 stimulated MMP1 gene transcription, net mRNA levels, protein and promoter reporter activity in HCF. This response was blocked by IL-17R/Fc chimera and IL-17R antibodies, but not by IL-6, TNF-
or IL-1
antibodies. IL-17-stimulated type I collagenase activity was inhibited by MMP inhibitor GM6001 and by siRNA-mediated MMP1 knockdown. IL-17 stimulated AP-1 (c-Fos, c-Jun, Fra-1), NF-
B (p50, p65) and C/EBP () DNA binding and reporter gene activities, effects attenuated by antisense oligonucleotides, siRNA-mediated knockdown, or expression of dominant negative signaling proteins. Inhibition of AP-1, NF-B or C/EBP activation attenuated IL-17-stimulated MMP1 expression. IL-17 induced p38 MAPK and ERK1/2 activation, and inhibition by SB203580 and PD98059 blunted IL-17-mediated TF activation and MMP1 expression. Our data indicate that IL-17 induces MMP1 in human cardiac fibroblasts directly via p38 MAPK- and ERK-dependent AP-1, NF-B and C/EBP activation, and suggest that IL-17 may play a critical role in myocardial remodeling.
This article has been cited by other articles:
|
|
 |
|
  E. Kobayashi, M. Kobayashi, K. Tsuneyama, T. Fukami, M. Nakajima, and T. Yokoi Halothane-Induced Liver Injury is Mediated by Interleukin-17 in Mice Toxicol. Sci., October 1, 2009; 111(2): 302 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Shen, N. Li, P. Gade, D. V. Kalvakolanu, T. Weibley, B. Doble, J. R. Woodgett, T. D. Wood, and S. L. Gaffen IL-17 Receptor Signaling Inhibits C/EBP{beta} by Sequential Phosphorylation of the Regulatory 2 Domain Sci. Signal., February 24, 2009; 2(59): ra8 - ra8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Mercer, A. M. Wallace, C. E. Brinckerhoff, and J. M. D'Armiento Identification of a Cigarette Smoke-Responsive Region in the Distal MMP-1 Promoter Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 4 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Venkatachalam, S. Mummidi, D. M. Cortez, S. D. Prabhu, A. J. Valente, and B. Chandrasekar Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2078 - H2087. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
